CVE-2024-38213
Published: August 13, 2024
Official Description
Microsoft Windows SmartScreen contains a security feature bypass vulnerability that allows an attacker to bypass the SmartScreen user experience via a malicious file.
CISA KEV Advisory
Microsoft Windows SmartScreen Security Feature Bypass Vulnerability
Microsoft Windows SmartScreen contains a security feature bypass vulnerability that allows an attacker to bypass the SmartScreen user experience via a malicious file.
Apply mitigations per vendor instructions or discontinue use of the product if mitigations are unavailable.
Risk Analysis
Microsoft Windows SmartScreen contains a security feature bypass vulnerability that allows an attacker to bypass the SmartScreen user experience with a malicious file. The high EPSS score of 0.59323 and confirmed exploitation indicate this is a significant risk, as it undermines a key security control.
This vulnerability is actively exploited in the wild and is included in CISA's KEV catalog. Exploitation involves a user interacting with a malicious file.
Apply the latest security updates from Microsoft for Windows. Educate users about the risks of opening untrusted files and implement strong endpoint protection.
Technical Analysis
CVE-2024-38213 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2024-38213 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Affected Vendors & Products
Exploit & PoC Resources
All References (2)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2024-38213 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1